English to Russian Medical Medical: Pharmaceuticals

Three summary measures were assessed. The first estimated incidence rates (unique patients with events per 100 patient-years’ exposure) for each agent, utilizing a random-effects meta-analytic model [14] with a restricted maximum likelihood estimator for between- study variances. The second and third strategies estimated relative risk (risk ratios) and risk differences for serious infec- tions (with 95 % confidence intervals [CIs]), versus control, for each agent across randomized controlled trials up to rescue of patients randomized to receive placebo.